fluconazole has been researched along with mycophenolic acid in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, TK; Ensom, MH; Kiang, TK | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ghosh, I; Manoharlal, R; Prakash, O; Prasad, R; Puri, N; Sharma, M | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Blundell, R; Butler, MS; Cooper, MA; Fraser, JA; Furlong, E; Kappler, U; Kobe, B; Kummari, LK; Nouwens, A; Robertson, AAB; Silva, AB | 1 |
| Bartlett, ST; Burke, GW; Gruessner, RW; Stock, PG | 1 |
| Coleman, DC; Moran, GP; Morschhäuser, J; Staib, P; Sullivan, DJ | 1 |
| Anderson, JB; Cowen, LE; Kohn, LM | 1 |
| Balken, E; Carey, JC; Leen-Mitchell, M; Martinez, L; Robertson, J | 1 |
| Byekova, Y; Elewski, B; Hughey, L | 1 |
| Cagnoli, GA; Cassina, M; Clementi, M; Di Gianantonio, E; Zuccarello, D | 1 |
4 review(s) available for fluconazole and mycophenolic acid
| Article | Year |
|---|---|
UDP-glucuronosyltransferases and clinical drug-drug interactions.
Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic | 2005 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Determination of human teratogenicity by the astute clinician method: review of illustrative agents and a proposal of guidelines.
Topics: Abnormalities, Drug-Induced; Antifungal Agents; Antirheumatic Agents; Congenital Abnormalities; Evidence-Based Medicine; Female; Fetus; Fluconazole; Humans; Immunosuppressive Agents; Infant, Newborn; Mycophenolic Acid; Penicillamine; Practice Guidelines as Topic; Pregnancy; Teratogens | 2009 |
Systemic drugs in patients with skin diseases.
Topics: Cyclosporine; Fluconazole; Glucocorticoids; Humans; Immunologic Factors; Immunosuppression Therapy; Itraconazole; Methotrexate; Mycophenolic Acid; Naphthalenes; Retinoids; Skin Diseases; Terbinafine | 2011 |
8 other study(ies) available for fluconazole and mycophenolic acid
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
Topics: Candida albicans; Membrane Transport Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Substrate Specificity | 2010 |
Antifungal benzo[b]thiophene 1,1-dioxide IMPDH inhibitors exhibit pan-assay interference (PAINS) profiles.
Topics: Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Fungal Proteins; HEK293 Cells; Hep G2 Cells; Humans; IMP Dehydrogenase; Models, Molecular; Oxadiazoles; Thiophenes | 2018 |
Suggested guidelines for the use of tacrolimus in pancreas/kidney transplantation.
Topics: Administration, Oral; Antifungal Agents; Antiviral Agents; Drug Interactions; Drug Therapy, Combination; Fluconazole; Graft Rejection; Guidelines as Topic; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Mycoses; Pancreas Transplantation; Tacrolimus; United States; Virus Diseases | 1998 |
Isogenic strain construction and gene targeting in Candida dubliniensis.
Topics: Antifungal Agents; Artificial Gene Fusion; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benomyl; Candida; Cloning, Molecular; Dose-Response Relationship, Drug; Fluconazole; Fungal Proteins; Fungicides, Industrial; Gene Deletion; Gene Expression; Genes, Reporter; Genome, Fungal; Green Fluorescent Proteins; Luminescent Proteins; Molecular Sequence Data; Mycophenolic Acid | 2001 |
Divergence in fitness and evolution of drug resistance in experimental populations of Candida albicans.
Topics: Antifungal Agents; Biological Evolution; Candida albicans; Culture Media; Drug Resistance, Microbial; Fluconazole; Humans; Microbial Sensitivity Tests; Mycophenolic Acid | 2001 |
Human teratogens and genetic phenocopies. Understanding pathogenesis through human genes mutation.
Topics: Abnormalities, Drug-Induced; Angiotensin-Converting Enzyme Inhibitors; Animals; Female; Fetal Diseases; Fetus; Fluconazole; Humans; Isoxazoles; Leflunomide; Mutation; Mycophenolic Acid; Phenotype; Pregnancy; Teratogenesis; Teratogens; Thalidomide; Warfarin | 2017 |